[Clinical biochemical justification for the use of fibrinolysis inhibitors in the therapy of hemorrhages in ENT diseases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy*; D006487:Hemostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*
D000933:Antifibrinolytic Agents
Kliniko-biokhimicheskie obosnovaniia primeneniia ingibitorov fibrinoliza v terapii krovotecheniĭ pri LORzabolevaniiakh